David Earp, Circle Pharma CEO

Cir­cle Phar­ma rais­es $54M as part of Se­ries D while macro­cy­cles heat up

Cir­cle Phar­ma, a start­up work­ing on macro­cy­cles for the “un­drug­gable,” is seek­ing about $117 mil­lion for a Se­ries D.

The com­pa­ny re­cent­ly closed the first …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.